日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VimR is a conserved master transcription regulator controlling virulence and metabolism in Pseudomonas

VimR是铜绿假单胞菌中控制毒力和代谢的保守主转录调控因子。

Fang Chen ,Yue Sun ,Jiadai Huang ,Tianmin Li ,Beifang Lu ,Zhe He ,Jingwei Li ,Tianqi Wang ,Haiyan Hu ,Xin Deng

A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma

一项针对晚期肉瘤患者的 I 期研究,评估 CSF1R 抑制剂 vimseltinib 与 PD-L1 抑制剂 avelumab 联合用药的疗效。

E Rosenbaum ,K Seier ,M Bradic ,S Movva ,C M Kelly ,M A Dickson ,M L Keohan ,M M Gounder ,P Chi ,B A Nacev ,J E Chan ,V Avutu ,M Biniakewitz ,S Jasnani ,M Duchemin ,R Desir ,P Wong ,J Erinjeri ,S Hwang ,C R Antonescu ,L-X Qin ,W D Tap ,S P D'Angelo

VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma

VIM-AS1受CpG甲基化调控,与IGF2BP1协同作用,通过降解EPHA3抑制肝细胞癌的侵袭性。

Su-Hyang Han #,Je Yeong Ko #,Sungju Jung,Sumin Oh,Do Yeon Kim,Eunseo Kang,Myung Sup Kim,Kyung-Hee Chun,Kyung Hyun Yoo,Jong Hoon Park

The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination

抗SARS-CoV-2单克隆抗体bamlanivimab对COVID-19疫苗的内源性免疫反应影响甚微。

Robert J Benschop ,Jay L Tuttle ,Lin Zhang ,Josh Poorbaugh ,Nicole L Kallewaard ,Peter Vaillancourt ,Melissa Crisp ,Thi Ngoc Vy Trinh ,Joshua J Freitas ,Stephanie Beasley ,Montanea Daniels ,Natalie Haustrup ,Richard E Higgs ,Ajay Nirula ,Myron S Cohen ,Mary Marovich

Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients

微小帕尔维莫纳斯菌(Parvimonas micra)促进结直肠肿瘤发生,并与结直肠癌患者的预后相关。

Liuyang Zhao # ,Xiang Zhang # ,Yunfei Zhou ,Kaili Fu ,Harry Cheuk-Hay Lau ,Tommy Wai-Yiu Chun ,Alvin Ho-Kwan Cheung ,Olabisi Oluwabukola Coker ,Hong Wei ,William Ka-Kei Wu ,Sunny Hei Wong ,Joseph Jao-Yiu Sung ,Ka Fai To ,Jun Yu

Stable nebulization and muco-trapping properties of regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19

regdanvimab/IN-006 具有稳定的雾化性和黏液捕获特性,支持其开发成为一种强效、低剂量的 COVID-19 吸入疗法。

Morgan D McSweeney ,Ian Stewart ,Zach Richardson ,Hyunah Kang ,Yoona Park ,Cheolmin Kim ,Karthik Tiruthani ,Whitney Wolf ,Alison Schaefer ,Priya Kumar ,Harendra Aurora ,Jeff Hutchins ,Jong Moon Cho ,Anthony J Hickey ,Soo Young Lee ,Samuel K Lai

Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts

自噬促进滑膜成纤维细胞中波形蛋白(VIM)的瓜氨酸化及其与主要组织相容性复合体II类分子的相互作用。

Eri Sugawara ,Masaru Kato ,Yuki Kudo ,Wenshi Lee ,Ryo Hisada ,Yuichiro Fujieda ,Kenji Oku ,Toshiyuki Bohgaki ,Olga Amengual ,Shinsuke Yasuda ,Tomohiro Onodera ,Shigetsugu Hatakeyama ,Tatsuya Atsumi

Vimentin expression is retained in erythroid cells differentiated from human iPSC and ESC and indicates dysregulation in these cells early in differentiation

人诱导多能干细胞(iPSC)和胚胎干细胞(ESC)分化而来的红系细胞中波形蛋白(Vimentin)的表达得以保留,表明这些细胞在分化早期就存在表达失调。

Kongtana Trakarnsanga ,Daniel Ferguson ,Deborah E Daniels ,Rebecca E Griffiths ,Marieangela C Wilson ,Kathryn E Mordue ,Abi Gartner ,Tatyana N Andrienko ,Annabel Calvert ,Alison Condie ,Angela McCahill ,Joanne C Mountford ,Ashley M Toye ,David J Anstee ,Jan Frayne

Metabolome variations in the Porphyromonas gingivalis vimA mutant during hydrogen peroxide-induced oxidative stress

过氧化氢诱导的氧化应激过程中牙龈卟啉单胞菌vimA突变体的代谢组变化

R M E McKenzie ,W Aruni, N A Johnson, A Robles, Y Dou, L Henry, D S Boskovic, H M Fletcher